Standout Papers
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density (2014)
- Postmenopausal osteoporosis (2016)
- Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS (2017)
- Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS (2020)
- Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024 (2024)
Immediate Impact
1 by Nobel laureates 26 from Science/Nature 62 standout
Citing Papers
CGRP sensory neurons promote tissue healing via neutrophils and macrophages
2024 StandoutNature
Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial
2024 Standout
Works of Bente Langdahl being referenced
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
2014 Standout
Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Bente Langdahl | 4513 | 3231 | 3826 | 228 | 8.6k | |
| Takayuki Hosoi | 3156 | 1786 | 3051 | 219 | 8.7k | |
| Silvano Adami | 4707 | 4023 | 2770 | 133 | 8.2k | |
| Cesar Libanati | 6858 | 4975 | 4316 | 147 | 9.5k | |
| Matthew T. Drake | 3435 | 3541 | 4673 | 121 | 10.6k | |
| J Štěpán | 3568 | 2558 | 2093 | 225 | 6.3k | |
| Murray J. Favus | 4125 | 2900 | 2162 | 127 | 8.8k | |
| Frederick R. Singer | 2807 | 4906 | 2748 | 180 | 10.1k | |
| Peter Pietschmann | 2599 | 1841 | 2587 | 255 | 7.2k | |
| Andreas Grauer | 4948 | 3573 | 3470 | 123 | 7.6k | |
| Henry G. Bone | 7543 | 7436 | 4966 | 147 | 11.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...